FDA Adverse Event Injury Summary report: N

HMS PLUS INSTRUMENT

MDR report key: 4100442 · Received September 19, 2014

Report

Report Number
2184009-2014-00069
Event Type
Injury
Date Received
September 19, 2014
Date of Event
March 28, 2014
Report Date
September 24, 2014
Manufacturer
PERFUSION SYSTEMS
Product Code
JOX
PMA / PMN Number
K101271
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS SUPPLEMENTAL REPORT IS SUBMITTED IN ORDER TO CORRECT THE INITIAL REPORT FROM A REPORTABLE SERIOUS INJURY TO A NON-REPORTABLE EV ENT. EVALUATION OF THIS PRODUCT EVENT INDICATES THAT THE DEVICE DID NOT CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY. INFORMATION RECEIVED FROM THE FIELD INDICATES THAT THERE WAS NO PATIENT HARM AS A RESULT OF THIS PRODUCT EVENT. ADDITIONALLY, EVALUATION OF THE DEVICE EVENT DATA SHOWED THAT THE DEVICE PERFORMED AS EXPECTED, INDICATING NO MALFUNCTION. ADDITIONALLY, A REVIEW OF PRIOR EVENTS INDICATES THAT, FOR THIS PRODUCT OR SIMILAR PRODUCT, THE PRODUCT EVENT IS NOT SUSPECTED TO HAVE BEEN A CAUSE, OR CONTRIBUTORY CAUSE, OF ANY PREVIOUS INCIDENTS THAT HAVE LED TO DEATH OR SERIOUS INJURY. BASED ON THE INFORMATION ABOVE, MEDTRONIC CONCLUDED THAT THIS DEVICE DID NOT CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY AND THE EVENT WOULD NOT LIKELY CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF IT WERE TO RECUR. (B)(4).

Additional Manufacturer Narrative · 1

EVENT INVESTIGATION REMAINS IN PROGRESS AND THE INSTRUMENT REMAINS WITH THE CUSTOMER IN THE FIELD. HOWEVER, PRELIMINARY ANALYSIS PERFORMED IN THE FIELD SHOWED THAT THE DEVICE PERFORMED AS INTENDED. THERE WERE NO PRODUCT ISSUES OR MALFUNCTIONS DETECTED THAT WOULD HAVE IMPACTED THIS EVENT. PATIENT AND DEVICE INFORMATION HAS BEEN REQUESTED. IF ADDITIONAL INFORMATION IS RECEIVED A SUPPLEMENTAL REPORT WILL BE FILED. (B)(4).

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION REPORTING THAT DURING USE OF THIS HMS PLUS IN A PROCEDURE, THE COAGULATION TEST RESULTS DID NOT MEET THE USER'S EXPECTATIONS AS BLOOD COTS APPEARED ON THE PERICARDIUM. THE USER DOUBTED THE ACCURACY OF THE INSTRUMENT. USE OF THE INSTRUMENT WAS CONTINUED WITH NO RESULTING ADVERSE PATIENT IMPACT. THE INSTRUMENT WAS INSPECTED BY MEDTRONIC FRANCE SERVICE AND REMAINS IN USE. ADDITIONAL INFORMATION HAS BEEN REQUESTED. THE DETAILS OF THE EVENT WERE SUMMARIZED AS FOLLOWS: O T=0 NORMAL COAGULATION O BYPASS LASTED 165 MIN AND ACTIVATED CLOTTING TIME (ACT) WAS BETWEEN 430 AND 460 SECONDS DURING THAT TIME. BLOOD CLOTS APPEARED ON THE PERICARDIUM AND THE MEASURE OF ACT WAS 451, ANOTHER MEASURE OF ACT MADE WITH ANOTHER MACHINE AND GAVE ACT OF 456 SEC. O INJECTION OF 19000UI OF HEPARIN AND THE END OF THE PROCEDURE

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
585116 HMS PLUS INSTRUMENT ANALYZER, HEPARIN, AUTOMATED JOX PERFUSION SYSTEMS 30514

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening